Clinical Trial Update: Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM) [NA]

View source ↗

Summary

An ongoing clinical trial (STORMM) evaluating middle meningeal artery embolization for chronic subdural hematomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: University Hospital, Geneva | Conditions: Chronic Subdural Hematomas, Cerebral Compression Due to Injury | NA | Status: RECRUITING